PCA
ABBV icon

Personal Capital Advisors’s AbbVie ABBV Stock Holding History

Personal Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$64.9M Buy
401,477
+33,696
+9% +$5.17M 0.32% 74
2022
Q3 		$49.4M Buy
367,781
+353,300
+2,440% +$50.7M 0.27% 85
2022
Q2 		$2.22M Sell
14,481
-1,994
-12% -$305K 0.01% 208
2022
Q1 		$2.67M Sell
16,475
-82
-0.5% -$11.9K 0.01% 210
2021
Q4 		$2.24M Buy
16,557
+459
+3% +$54.2K 0.01% 223
2021
Q3 		$1.74M Buy
16,098
+1,801
+13% +$206K 0.01% 230
2021
Q2 		$1.61M Sell
14,297
-5,548
-28% -$625K 0.01% 232
2021
Q1 		$2.15M Sell
19,845
-2,177
-10% -$233K 0.01% 226
2020
Q4 		$2.36M Buy
22,022
+2,771
+14% +$266K 0.02% 223
2020
Q3 		$1.69M Buy
19,251
+594
+3% +$55.9K 0.01% 234
2020
Q2 		$1.83M Buy
18,657
+5,838
+46% +$514K 0.02% 214
2020
Q1 		$969K Buy
12,819
+1,158
+10% +$98.6K 0.01% 225
2019
Q4 		$1.03M Buy
11,661
+1,437
+14% +$119K 0.01% 232
2019
Q3 		$774K Buy
10,224
+1
+0% +$69 0.01% 231
2019
Q2 		$743K Buy
10,223
+1,626
+19% +$128K 0.01% 223
2019
Q1 		$693K Sell
8,597
-2,273
-21% -$186K 0.01% 224
2018
Q4 		$1M Buy
10,870
+2,208
+25% +$194K 0.01% 198
2018
Q3 		$819K Buy
8,662
+1,269
+17% +$120K 0.01% 196
2018
Q2 		$685K Buy
7,393
+1,154
+18% +$113K 0.01% 192
2018
Q1 		$591K Sell
6,239
-1,302
-17% -$143K 0.01% 184
2017
Q4 		$729K Buy
7,541
+2,634
+54% +$248K 0.01% 183
2017
Q3 		$436K Buy
4,907
+1,999
+69% +$152K 0.01% 185
2017
Q2 		$211K Buy
+2,908
New +$195K ﹤0.01% 211

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Personal Capital Advisors's ABBV Position: Q4 2022 in Review

Personal Capital Advisors increased its AbbVie (ABBV) stake by 9.2% in Q4 2022, buying an estimated $5.17M and bringing the position to 401,477 shares worth $64.9M. The position accounts for 0.32% of the portfolio, ranked #74.

Personal Capital Advisors first reported a position in ABBV in Q2 2017 and has held it in 23 quarters since. 3,171 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Personal Capital Advisors held 401,477 shares of AbbVie worth $64.9M as of Q4 2022.
  • Personal Capital Advisors bought 33,696 AbbVie shares in Q4 2022, an estimated $5.17M.
  • AbbVie made up 0.32% of Personal Capital Advisors's portfolio in Q4 2022, its #74 holding.
  • Personal Capital Advisors first reported a position in AbbVie in Q2 2017 and has held it in 23 quarters since.
  • 3,171 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.